Illumina Inc
ILMN: XNAS (USA)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
$144.00 | Qddtfp | Tnbwxkn |
Illumina Delivers Weak End to 2022 and Maintains Outlook for 2023; No Fair Value Change
After releasing preliminary 2022 results and 2023 guidance in January, narrow-moat Illumina released full quarterly results that represented a weak end to a miserable year. However, management maintained its guidance for 2023, and we retain our $269 fair value estimate. We still view shares as undervalued.